• Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the KidneyHalimi, Jean-Michel; Sarafidis, Pantelis; Azizi, Michel; Bilo, Grzegorz; Burkard, Thilo; Bursztyn, Michael; Camafort, Miguel; Chapman, Neil; Cottone, Santina; de Backer, Tine; Deinum, Jaap; Delmotte, Philippe; Viigimaa, MargusBlood Pressure2024 / art. 2368800 https://doi.org/10.1080/08037051.2024.2368800 https://www.scopus.com/sourceid/22490 https://www.scopus.com/record/display.uri?eid=2-s2.0-85197004664&origin=resultslist&sort=plf-f&src=s&sot=b&sdt=b&s=DOI%2810.1080%2F08037051.2024.2368800%29&sessionSearchId=971b6d536926a71d00c3665b57fa29cc&relpos=0
• The mechanisms of actions of aldosterone and its antagonists in cardiovascular diseasePantelidis, Panteleimon; Sideris, Michail; Viigimaa, Margus; Avranas, Konstantinos; Deligkaris, Pavlos; Zografou, Ioanna; Lovic, DraganCurrent Pharmaceutical Design2018 / p. 5491 - 5499 https://doi.org/10.2174/1381612825666190215100502 https://www.scopus.com/sourceid/20682 https://www.scopus.com/record/display.uri?eid=2-s2.0-85065822557&origin=inward&txGid=01bd8e3394a1f01356c9c3f69261a1ee https://jcr.clarivate.com/jcr-jp/journal-profile?journal=CURR%20PHARM%20DESIGN&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000465992600003